Keyword Index

Browse for an article via relevant keywords across our entire electronic archive

- Click on the first letter of the keyword:
  - A
  - B
  - C
  - D
  - E
  - F
  - H
  - I
  - J
  - K
  - L
  - M
  - N
  - O
  - P
  - Q
  - R
  - S
  - T
  - U
  - V
  - W
  - X
  - Y
  - Z
  - Other

Search results for: G
Results 41 - 50 of 306 shown below

ganciclovir

A R Buursma, I J van Dillen, A van Waarde, W Vaalburg, G A P Hospers, N H Mulder and E F J de Vries

Monitoring HSVtk suicide gene therapy: the role of [¹⁸F]FHPG membrane transport

doi:10.1038/sj.bjc.6602216

Abstract | Full article | PDF
gangliosides

M K Ranes, M El-Abbadi, M G Manfredi, P Mukherjee, F M Platt and T N Seyfried

N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours

doi:10.1054/bjoc.2000.1713

Abstract | Full article | PDF
M El-Abbadi, T N Seyfried, A J Yates, C Orosz and M C Lee

Ganglioside composition and histology of a spontaneous metastatic brain tumour in the VM mouse

doi:10.1054/bjoc.2001.1909

Abstract | Full article | PDF
GARFT inhibitor

D Bissett, H L McLeod, B Sheedy, M Collier, Y Pithavala, L Paradiso, M Pitsiladis and J Cassidy

Phase I dose-escalation and pharmacokinetic study of a novel folate analogue AG2034

doi:10.1054/bjoc.2000.1601

Abstract | Full article | PDF
garlic

T Lund, T Stokke, Ø E Olsen and Ø Fodstad

Garlic arrests MDA-MB-435 cancer cells in mitosis, phosphorylates the proapoptotic BH3-only protein Bim_EL and induces apoptosis

advance online publication, 2005-04-12 00:00:00.000;

doi:10.1038/sj.bjc.6602537

Abstract | Full article | PDF
gastrectomy

Y Leigh, V Seagroatt, M Goldacre and P McCulloch

Impact of socio-economic deprivation on death rates after surgery for upper gastrointestinal tract cancer

advance online publication, 2006-08-22 00:00:00.000;

doi:10.1038/sj.bjc.6603315

Abstract | Full article | PDF
gastric

M Moehler, A Eimermacher, J Siebler, T Höhler, A Wein, M Menges, D Flieger, T Junginger, T Geer, E Gracien, P R Galle and M Heike

Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer

advance online publication, 2005-06-07 00:00:00.000;

doi:10.1038/sj.bjc.6602649

Abstract | Full article | PDF
E Chandanos, M Lindblad, C Jia, C A Rubio, W Ye and J Lagergren

Tamoxifen exposure and risk of oesophageal and gastric adenocarcinoma: a population-based cohort study of breast cancer patients in Sweden

advance online publication, 2006-06-06 00:00:00.000;

doi:10.1038/sj.bjc.6603214

Abstract | Full article | PDF
S A Suttie, K G M Park and T A D Smith

[¹⁸F]2-Fluoro-2-deoxy-D-glucose incorporation by AGS gastric adenocarcinoma cells in vitro during response to epirubicin, cisplatin and 5-fluorouracil

advance online publication, 2007-09-11 00:00:00.000;

doi:10.1038/sj.bjc.6603971

Abstract | Full article | PDF
L M Smith, A Nesterova, M C Ryan, S Duniho, M Jonas, M Anderson, R F Zabinski, M K Sutherland, H-P Gerber, K L Van Orden, P A Moore, S M Ruben and P J Carter

CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers

advance online publication, 2008-06-10 00:00:00.000;

doi:10.1038/sj.bjc.6604437

Abstract | Full article | PDF
Y Mohri, T Mohri, W Wei, Y-J Qi, A Martin, C Miki, M Kusunoki, D G Ward and P J Johnson

Identification of macrophage migration inhibitory factor and human neutrophil peptides 1–3 as potential biomarkers for gastric cancer

advance online publication, 2009-06-23 00:00:00.000;

doi:10.1038/sj.bjc.6605138

Abstract | Full article | PDF
J S Waters, A Norman, D Cunningham, J H Scarffe, A Webb, P Harper, J K Joffe, M Mackean, J Mansi, M Leahy, A Hill, J Oates, S Rao, M Nicolson and T Hickish

Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial

doi:10.1038/sj.bjc.6690350

Abstract | Full article | PDF
gastric adenocarcinoma

D E Burgess, C B Woodman, K J Flavell, D C Rowlands, J Crocker, K Scott, J P Biddulph, L S Young and P G Murray

Low prevalence of Epstein-Barr virus in incident gastric adenocarcinomas from the United Kingdom

doi:10.1038/sj.bjc.6600107

Abstract | Full article | PDF
H Takenawa, M Kurosaki, N Enomoto, Y Miyasaka, N Kanazawa, N Sakamoto, T Ikeda, N Izumi, C Sato and M Watanabe

Differential gene-expression profiles associated with gastric adenoma

doi:10.1038/sj.bjc.6601399

Abstract | Full article | PDF
D H Lim, D Y Kim, M K Kang, Y I Kim, W K Kang, C K Park, S Kim, J H Noh, J W Joh, S H Choi, T S Sohn, J S Heo, C H Park, J O Park, J E Lee, Y J Park, H R Nam, W Park, Y C Ahn and S J Huh

Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view

advance online publication, 2004-05-25 00:00:00.000;

doi:10.1038/sj.bjc.6601896

Abstract | Full article | PDF
H-C Jeung, S Y Rha, S J Shin, J B Ahn, S H Noh, J K Roh and H C Chung

A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status

advance online publication, 2007-07-24 00:00:00.000;

doi:10.1038/sj.bjc.6603902

Abstract | Full article | PDF
S Senapati, P Chaturvedi, P Sharma, G Venkatraman, J L Meza, W El-Rifai, H K Roy and S K Batra

Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancer

doi:10.1038/sj.bjc.6604632

Abstract | Full article | PDF
L Duan, A H Wu, J Sullivan-Halley and L Bernstein

Passive smoking and risk of oesophageal and gastric adenocarcinomas

advance online publication, 2009-04-07 00:00:00.000;

doi:10.1038/sj.bjc.6605023

Abstract | Full article | PDF
C-W Wu, Y-Y Lin, G-D Chen, C-W Chi, D P Carbone and J-Y Chen

Serum anti-p53 antibodies in gastric adenocarcinoma patients are associated with poor prognosis, lymph node metastasis and poorly differentiated nuclear grade

doi:10.1038/sj.bjc.6690382

Abstract | Full article | PDF
K Kashiwagi, M Watanabe, T Ezaki, T Kanai, H Ishii, M Mukai and T Hibi

Clinical usefulness of microsatellite instability for the prediction of gastric adenoma or adenocarcinoma in patients with chronic gastritis

doi:10.1054/bjoc.1999.1154

Abstract | Full article | PDF
gastric adenoma

H Takenawa, M Kurosaki, N Enomoto, Y Miyasaka, N Kanazawa, N Sakamoto, T Ikeda, N Izumi, C Sato and M Watanabe

Differential gene-expression profiles associated with gastric adenoma

doi:10.1038/sj.bjc.6601399

Abstract | Full article | PDF
K Kashiwagi, M Watanabe, T Ezaki, T Kanai, H Ishii, M Mukai and T Hibi

Clinical usefulness of microsatellite instability for the prediction of gastric adenoma or adenocarcinoma in patients with chronic gastritis

doi:10.1054/bjoc.1999.1154

Abstract | Full article | PDF
M J Baek, H Kang, S E Kim, J H Park, J S Lee, Y-K Paik and H Kim

Expression of hMLH1 is inactivated in the gastric adenomas with enhanced microsatellite instability

doi:10.1054/bjoc.2001.2051

Abstract | Full article | PDF
gastric cancer

K Sakata, G Tamura, Y Endoh, K Ohmura, S Ogata and T Motoyama

Hypermethylation of the hMLH1 gene promoter in solitary and multiple gastric cancers with microsatellite instability

doi:10.1038/sj.bjc.6600076

Abstract | Full article | PDF
A Cuschieri, I C Talbot and S Weeden

Influence of pathological tumour variables on long-term survival in resectable gastric cancer

doi:10.1038/sj.bjc.6600161

Abstract | Full article | PDF
G de Manzoni, G Pelosi, F Pavanel, A Di Leo, C Pedrazzani, E Durante, C Cordiano and F Pasini

The presence of bone marrow cytokeratin-immunoreactive cells does not predict outcome in gastric cancer patients

doi:10.1038/sj.bjc.6600211

Abstract | Full article | PDF
J-H Choi, H-Y Lim, H J Joo, H S Kim, J W Yi, H C Kim, Y K Cho, M W Kim and K B Lee

Expression of multidrug resistance-associated protein1,P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection

doi:10.1038/sj.bjc.6600305

Abstract | Full article | PDF
S R Bramhall, M T Hallissey, J Whiting, J Scholefield, G Tierney, R C Stuart, R E Hawkins, P McCulloch, T Maughan, P D Brown, M Baillet and J W L Fielding

Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial

doi:10.1038/sj.bjc.6600310

Abstract | Full article | PDF
G V Kornek, M Raderer, B Schüll, W Fiebiger, C Gedlicka, A Lenauer, D Depisch, B Schneeweiss, F Lang and W Scheithauer

Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and/or erythropoietin in patients with advanced gastric cancer

doi:10.1038/sj.bjc.6600345

Abstract | Full article | PDF
J Yu, W K Leung, M P A Ebert, E K W Ng, M Y Y Go, H B Wang, S C S Chung, P Malfertheiner and J J Y Sung

Increased expression of survivin in gastric cancer patients and in first degree relatives

doi:10.1038/sj.bjc.6600421

Abstract | Full article | PDF
G de Manzoni, G Verlato, F Roviello, P Morgagni, A Di Leo, L Saragoni, D Marrelli, H Kurihara and F Pasini

The new TNM classification of lymph node metastasis minimises stage migration problems in gastric cancer patients

doi:10.1038/sj.bjc.6600432

Abstract | Full article | PDF
C Sakakura, A Hagiwara, M Nakanishi, K Shimomura, T Takagi, R Yasuoka, Y Fujita, T Abe, Y Ichikawa, S Takahashi, T Ishikawa, I Nishizuka, T Morita, H Shimada, Y Okazaki, Y Hayashizaki and H Yamagishi

Differential gene expression profiles of gastric cancer cells established from primary tumour and malignant ascites

doi:10.1038/sj.bjc.6600580

Abstract | Full article | PDF
M Akagi, M Kawaguchi, W Liu, M F McCarty, A Takeda, F Fan, O Stoeltzing, A A Parikh, Y D Jung, C D Bucana, P F Mansfield, D J Hicklin and L M Ellis

Induction of neuropilin-1 and vascular endothelial growth factor by epidermal growth factor in human gastric cancer cells

doi:10.1038/sj.bjc.6600811

Abstract | Full article | PDF
S Yoshimura, T Yamada, S Ohwada, T Koyama, K Hamada, K Tago, I Sakamoto, I Takeyoshi, T Ikeya, F Makita, Y Iino and Y Morishita

Mutations in the ST7/RAY1/HELG locus rarely occur in primary colorectal, gastric, and hepatocellular carcinomas

doi:10.1038/sj.bjc.6600942

Abstract | Full article | PDF
A Varis, B van Rees, M Weterman, A Ristimäki, J Offerhaus and S Knuutila

DNA copy number changes in young gastric cancer patients with special reference to chromosome 19

doi:10.1038/sj.bjc.6600969

Abstract | Full article | PDF
H Ajisaka and K Miwa

Micrometastases in sentinel nodes of gastric cancer

doi:10.1038/sj.bjc.6601183

Abstract | Full article | PDF
F Graziano, D Santini, E Testa, V Catalano, G D Beretta, S Mosconi, G Tonini, V Lai, R Labianca and S Cascinu

A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer

doi:10.1038/sj.bjc.6601280

Abstract | Full article | PDF
C Morgan, G J S Jenkins, T Ashton, A P Griffiths, J N Baxter, E M Parry and J M Parry

Detection of p53 mutations in precancerous gastric tissue

doi:10.1038/sj.bjc.6601302

Abstract | Full article | PDF
T Leong, M Michael, K Foo, A Thompson, D Lim Joon, L Weih, S Ngan, R Thomas and J Zalcberg

Adjuvant and neoadjuvant therapy for gastric cancer using epirubicin/cisplatin/5-fluorouracil (ECF) and alternative regimens before and after chemoradiation

doi:10.1038/sj.bjc.6601311

Abstract | Full article | PDF
J T Hartmann, K Oechsle, D Quietzsch, A Wein, R D Hofheinz, F Honecker, O Nehls, C-H Köhne, G Käfer, L Kanz and C Bokemeyer

Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study

doi:10.1038/sj.bjc.6601412

Abstract | Full article | PDF
C Fondevila, J P Metges, J Fuster, J J Grau, A Palacín, A Castells, A Volant and M Pera

p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer

doi:10.1038/sj.bjc.6601455

Abstract | Full article | PDF
C Sakakura, M Takemura, A Hagiwara, K Shimomura, K Miyagawa, S Nakashima, T Yoshikawa, T Takagi, S Kin, Y Nakase, J Fujiyama, Y Hayasizaki, Y Okazaki and H Yamagishi

Overexpression of dopa decarboxylase in peritoneal dissemination of gastric cancer and its potential as a novel marker for the detection of peritoneal micrometastases with real-time RT–PCR

doi:10.1038/sj.bjc.6601544

Abstract | Full article | PDF
T Honda, G Tamura, T Waki, S Kawata, M Terashima, S Nishizuka and T Motoyama

Demethylation of MAGE promoters during gastric cancer progression

doi:10.1038/sj.bjc.6601600

Abstract | Full article | PDF
K Kawaguchi, K Yashima, M Koda, A Tsutsumi, S Kitaoka, H Andachi, A Hosoda, Y Kishimoto, G Shiota, H Ito and Y Murawaki

Fhit expression in human gastric adenomas and intramucosal carcinomas: correlation with Mlh1 expression and gastric phenotype

doi:10.1038/sj.bjc.6601601

Abstract | Full article | PDF
S Cascinu, M Scartozzi, R Labianca, V Catalano, R R Silva, S Barni, A Zaniboni, A D'Angelo, S Salvagni, G Martignoni, G D Beretta, F Graziano, R Berardi and V Franciosi

High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract

advance online publication, 2004-03-30 00:00:00.000;

doi:10.1038/sj.bjc.6601752

Abstract | Full article | PDF
R-D Hofheinz, A Willer, A Weisser, U Gnad, S Saussele, S Kreil, J T Hartmann, R Hehlmann and A Hochhaus

Pegylated liposomal doxorubicin in combination with mitomycin C, infusional 5-fluorouracil and sodium folinic acid. A phase-I-study in patients with upper gastrointestinal cancer

advance online publication, 2004-04-13 00:00:00.000;

doi:10.1038/sj.bjc.6601786

Abstract | Full article | PDF
P Edwards, G R J C Blackshaw, W G Lewis, J D Barry, M C Allison and D R B Jones

Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma

advance online publication, 2004-05-04 00:00:00.000;

doi:10.1038/sj.bjc.6601790

Abstract | Full article | PDF
T Honda, G Tamura, T Waki, S Kawata, S Nishizuka and T Motoyama

Promoter hypermethylation of the Chfr gene in neoplastic and non-neoplastic gastric epithelia

advance online publication, 2004-04-27 00:00:00.000;

doi:10.1038/sj.bjc.6601849

Abstract | Full article | PDF
C-S Wang, K-H Lin, S-L Chen, Y-F Chan and S Hsueh

Overexpression of SPARC gene in human gastric carcinoma and its clinic–pathologic significance

advance online publication, 2004-11-23 00:00:00.000;

doi:10.1038/sj.bjc.6602213

Abstract | Full article | PDF
M Terashima, C Maesawa, K Oyama, S Ohtani, Y Akiyama, S Ogasawara, A Takagane, K Saito, T Masuda, N Kanzaki, S Matsuyama, Y Hoshino, M Kogure, M Gotoh, M Shirane and K Mori

Gene expression profiles in human gastric cancer: expression of maspin correlates with lymph node metastasis

advance online publication, 2005-03-15 00:00:00.000;

doi:10.1038/sj.bjc.6602429

Abstract | Full article | PDF
A Shin, H R Shin, D Kang, S K Park, C-S Kim and K-Y Yoo

A nested case–control study of the association of Helicobacter pylori infection with gastric adenocarcinoma in Korea

advance online publication, 2005-03-08 00:00:00.000;

doi:10.1038/sj.bjc.6602467

Abstract | Full article | PDF
M Scartozzi, E Galizia, F Graziano, V Catalano, R Berardi, A M Baldelli, E Testa, D Mari, R R Silva and S Cascinu

Over-D1 dissection may question the value of radiotherapy as a part of an adjuvant programme in high-risk radically resected gastric cancer patients

advance online publication, 2005-03-15 00:00:00.000;

doi:10.1038/sj.bjc.6602468

Abstract | Full article | PDF
I Songun, S V Litvinov, C J H van de Velde, S T Pals, J Hermans and J H J M van Krieken

Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer

doi:10.1038/sj.bjc.6602519

Abstract | Full article | PDF
L Williams, G J S Jenkins, S H Doak, P Fowler, E M Parry, T H Brown, A P Griffiths, J G Williams and J M Parry

Fluorescence in situ hybridisation analysis of chromosomal aberrations in gastric tissue: the potential involvement of Helicobacter pylori

advance online publication, 2005-04-12 00:00:00.000;

doi:10.1038/sj.bjc.6602533

Abstract | Full article | PDF
W K Leung, K-F To, E S H Chu, M W Y Chan, A H C Bai, E K W Ng, F K L Chan and J J Y Sung

Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer

advance online publication, 2005-06-07 00:00:00.000;

doi:10.1038/sj.bjc.6602636

Abstract | Full article | PDF
T Arigami, S Natsugoe, Y Uenosono, H Arima, Y Mataki, K Ehi, S Yanagida, S Ishigami, S Hokita and T Aikou

Lymphatic invasion using D2-40 monoclonal antibody and its relationship to lymph node micrometastasis in pN0 gastric cancer

advance online publication, 2005-08-30 00:00:00.000;

doi:10.1038/sj.bjc.6602739

Abstract | Full article | PDF
S Ito, H Nakanishi, Y Kodera, Y Mochizuki, M Tatematsu and Y Yamamura

Prospective validation of quantitative CEA mRNA detection in peritoneal washes in gastric carcinoma patients

advance online publication, 2005-10-04 00:00:00.000;

doi:10.1038/sj.bjc.6602802

Abstract | Full article | PDF
M Endoh, G Tamura, T Honda, N Homma, M Terashima, S Nishizuka and T Motoyama

RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer

advance online publication, 2005-11-01 00:00:00.000;

doi:10.1038/sj.bjc.6602854

Abstract | Full article | PDF
E Goekkurt, S Hoehn, C Wolschke, C Wittmer, C Stueber, D K Hossfeld and J Stoehlmacher

Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS) – novel predictors for response and survival in gastric cancer patients

advance online publication, 2005-11-29 00:00:00.000;

doi:10.1038/sj.bjc.6602891

Abstract | Full article | PDF
M Lindblad, L A García Rodríguez, E Chandanos and J Lagergren

Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas

advance online publication, 2005-12-13 00:00:00.000;

doi:10.1038/sj.bjc.6602906

Abstract | Full article | PDF
J Leyden, D Murray, A Moss, M Arumuguma, E Doyle, G McEntee, C O'Keane, P Doran and P MacMathuna

Net1 and Myeov: computationally identified mediators of gastric cancer

advance online publication, 2006-03-21 00:00:00.000;

doi:10.1038/sj.bjc.6603054

Abstract | Full article | PDF
M E Burge, D Smith, C Topham, D P Jackson, D A Anthoney, F Halstead and M T Seymour

A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma

advance online publication, 2006-04-11 00:00:00.000;

doi:10.1038/sj.bjc.6603084

Abstract | Full article | PDF
J H Baek, J G Kim, S B Jeon, Y S Chae, D H Kim, S K Sohn, K B Lee, Y J Choi, H J Shin, J S Chung, G J Cho, H Y Jung and W Yu

Phase II study of capecitabine and irinotecan combination chemotherapy in patients with advanced gastric cancer

advance online publication, 2006-04-25 00:00:00.000;

doi:10.1038/sj.bjc.6603093

Abstract | Full article | PDF
S R Park, J H Chun, M S Yu, J H Lee, K W Ryu, I J Choi, C G Kim, J S Lee, Y W Kim, J-M Bae and H K Kim

Phase II study of docetaxel and irinotecan combination chemotherapy in metastatic gastric carcinoma

advance online publication, 2006-04-25 00:00:00.000;

doi:10.1038/sj.bjc.6603133

Abstract | Full article | PDF
Y Chao, C P Li, T Y Chao, W C Su, R K Hsieh, M F Wu, K H Yeh, W Y Kao, L T Chen and A L Cheng

An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer

advance online publication, 2006-06-27 00:00:00.000;

doi:10.1038/sj.bjc.6603225

Abstract | Full article | PDF
M Jenab, E Riboli, P Ferrari, M Friesen, J Sabate, T Norat, N Slimani, A Tjønneland, A Olsen, K Overvad, M-C Boutron-Ruault, F Clavel-Chapelon, H Boeing, M Schulz, J Linseisen, G Nagel, A Trichopoulou, A Naska, E Oikonomou, F Berrino, S Panico, D Palli, C Sacerdote, R Tumino, P H Peeters, M E Numans, H B Bueno-de-Mesquita, F L Büchner, E Lund, G Pera, M D Chirlaque, M-J Sánchez, L Arriola, A Barricarte, J R Quirós, I Johansson, A Johansson, G Berglund, S Bingham, K-T Khaw, N Allen, T Key, F Carneiro, V Save, G Del Giudice, M Plebani, R Kaaks and C A Gonzalez

Plasma and dietary carotenoid, retinol and tocopherol levels and the risk of gastric adenocarcinomas in the European prospective investigation into cancer and nutrition

advance online publication, 2006-07-11 00:00:00.000;

doi:10.1038/sj.bjc.6603266

Abstract | Full article | PDF
M Scartozzi, E Galizia, L Verdecchia, R Berardi, F Graziano, V Catalano, P Giordani, D Mari, R R Silva, C Marmorale, C Zingaretti and S Cascinu

Lymphatic, blood vessel and perineural invasion identifies early-stage high-risk radically resected gastric cancer patients

advance online publication, 2006-08-01 00:00:00.000;

doi:10.1038/sj.bjc.6603286

Abstract | Full article | PDF
J Gwack, A Shin, C-S Kim, K-P Ko, Y Kim, J K Jun, J Bae, S K Park, Y-C Hong, D Kang, S-H Chang, H-R Shin and K-Y Yoo

CagA-producing Helicobacter pylori and increased risk of gastric cancer: a nested case–control study in Korea

advance online publication, 2006-08-08 00:00:00.000;

doi:10.1038/sj.bjc.6603309

Abstract | Full article | PDF
F Kamangar, Y-L Qiao, M J Blaser, X-D Sun, H Katki, J-H Fan, G I Perez-Perez, C C Abnet, P Zhao, S D Mark, P R Taylor and S M Dawsey

Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China

advance online publication, 2006-12-19 00:00:00.000;

doi:10.1038/sj.bjc.6603517

Abstract | Full article | PDF
E A Griffiths, S A Pritchard, H R Valentine, N Whitchelo, P W Bishop, M P Ebert, P M Price, I M Welch and C M L West

Hypoxia-inducible factor-1 expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas

advance online publication, 2006-12-19 00:00:00.000;

doi:10.1038/sj.bjc.6603524

Abstract | Full article | PDF
S Kamoshida, M Suzuki, R Shimomura, Y Sakurai, Y Komori, I Uyama and Y Tsutsumi

Immunostaining of thymidylate synthase and p53 for predicting chemoresistance to S-1/cisplatin in gastric cancer

advance online publication, 2007-01-09 00:00:00.000;

doi:10.1038/sj.bjc.6603546

Abstract | Full article | PDF
H Noda, Y Miyaji, A Nakanishi, F Konishi and Y Miki

Frequent reduced expression of alpha-1B-adrenergic receptor caused by aberrant promoter methylation in gastric cancers

doi:10.1038/sj.bjc.6603555

Abstract | Full article | PDF
B Neri, P Pantaleo, E Giommoni, R Grifoni, C Paoletti, V Rotella, D Pantalone, A Taddei, A Mercatelli and P Tonelli

Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study

advance online publication, 2007-03-13 00:00:00.000;

doi:10.1038/sj.bjc.6603644

Abstract | Full article | PDF
K Hemminki, J Sundquist and J Ji

Familial risk for gastric carcinoma: an updated study from Sweden

advance online publication, 2007-04-03 00:00:00.000;

doi:10.1038/sj.bjc.6603722

Abstract | Full article | PDF
L Rosero-Bixby and R Sierra

X-ray screening seems to reduce gastric cancer mortality by half in a community-controlled trial in Costa Rica

advance online publication, 2007-10-02 00:00:00.000;

doi:10.1038/sj.bjc.6603729

Abstract | Full article | PDF
Y Kosaka, K Mimori, T Fukagawa, K Ishikawa, T Etoh, H Katai, T Sano, M Watanabe, M Sasako and M Mori

Identification of the high-risk group for metastasis of gastric cancer cases by vascular endothelial growth factor receptor-1 overexpression in peripheral blood

advance online publication, 2007-05-08 00:00:00.000;

doi:10.1038/sj.bjc.6603785

Abstract | Full article | PDF
T Yamanaka, S Matsumoto, S Teramukai, R Ishiwata, Y Nagai and M Fukushima

Predictive value of chemotherapy-induced neutropenia for the efficacy of oral fluoropyrimidine S-1 in advanced gastric carcinoma

advance online publication, 2007-06-05 00:00:00.000;

doi:10.1038/sj.bjc.6603831

Abstract | Full article | PDF
W Chen, S M Dawsey, Y-L Qiao, S D Mark, Z-W Dong, P R Taylor, P Zhao and C C Abnet

Prospective study of serum 25(OH)-vitamin D concentration and risk of oesophageal and gastric cancers

advance online publication, 2007-06-05 00:00:00.000;

doi:10.1038/sj.bjc.6603834

Abstract | Full article | PDF
N Y Sung, K S Choi, E C Park, K Park, S Y Lee, A K Lee, I J Choi, K W Jung, Y J Won and H R Shin

Smoking, alcohol and gastric cancer risk in Korean men: the National Health Insurance Corporation Study

advance online publication, 2007-07-17 00:00:00.000;

doi:10.1038/sj.bjc.6603893

Abstract | Full article | PDF
P Kolodziejczyk, A Pituch-Noworolska, G Drabik, J Kulig, A Szczepanik, M Sierzega, A Gurda, T Popiela and M Zembala

The effects of preoperative chemotherapy on isolated tumour cells in the blood and bone marrow of gastric cancer patients

advance online publication, 2007-08-14 00:00:00.000;

doi:10.1038/sj.bjc.6603904

Abstract | Full article | PDF
Y Nakamura, F Tanaka, N Haraguchi, K Mimori, T Matsumoto, H Inoue, K Yanaga and M Mori

Clinicopathological and biological significance of mitotic centromere-associated kinesin overexpression in human gastric cancer

advance online publication, 2007-07-24 00:00:00.000;

doi:10.1038/sj.bjc.6603905

Abstract | Full article | PDF
K Katsuragi, M Yashiro, T Sawada, H Osaka, M Ohira and K Hirakawa

Prognostic impact of PCR-based identification of isolated tumour cells in the peritoneal lavage fluid of gastric cancer patients who underwent a curative R0 resection

advance online publication, 2007-07-31 00:00:00.000;

doi:10.1038/sj.bjc.6603909

Abstract | Full article | PDF
T Takayama, Y Sato, T Sagawa, T Okamoto, H Nagashima, Y Takahashi, H Ohnuma, G Kuroiwa, K Miyanishi, R Takimoto, T Matsunaga, J Kato, K Yamaguchi, K Hirata and Y Niitsu

Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer

advance online publication, 2007-09-11 00:00:00.000;

doi:10.1038/sj.bjc.6603957

Abstract | Full article | PDF
E P M Jansen, H Boot, R Dubbelman, H Bartelink, A Cats and M Verheij

Postoperative chemoradiotherapy in gastric cancer – a phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy

doi:10.1038/sj.bjc.6603965

Abstract | Full article | PDF
H Shoda, Y Kakugawa, D Saito, T Kozu, T Terauchi, H Daisaki, C Hamashima, Y Muramatsu, N Moriyama and H Saito

Evaluation of ¹⁸F-2-deoxy-2-fluoro-glucose positron emission tomography for gastric cancer screening in asymptomatic individuals undergoing endoscopy

advance online publication, 2007-11-27 00:00:00.000;

doi:10.1038/sj.bjc.6604062

Abstract | Full article | PDF
J Koshiol, Y-L Qiao, S D Mark, S M Dawsey, C C Abnet, F Kamangar, E T Lennette, Z-W Dong and P R Taylor

Epstein–Barr virus serology and gastric cancer incidence and survival

advance online publication, 2007-11-06 00:00:00.000;

doi:10.1038/sj.bjc.6604063

Abstract | Full article | PDF
C-W Wu, J-M Chiou, F-S Ko, S-S Lo, J-H Chen, W-Y Lui and J Whang-Peng

Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial

advance online publication, 2008-01-08 00:00:00.000;

doi:10.1038/sj.bjc.6604097

Abstract | Full article | PDF
Y Mizukami, K Kono, Y Kawaguchi, H Akaike, K Kamimura, H Sugai and H Fujii

Localisation pattern of Foxp3⁺ regulatory T cells is associated with clinical behaviour in gastric cancer

advance online publication, 2007-12-18 00:00:00.000;

doi:10.1038/sj.bjc.6604149

Abstract | Full article | PDF
J G Kim, S K Sohn, Y S Chae, H S Song, K-Y Kwon, Y R Do, M K Kim, K H Lee, M S Hyun, H M Ryoo, S H Bae, K U Park, W S Lee, J H Baek, H Y Chung and W Yu

Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology Group

advance online publication, 2008-01-22 00:00:00.000;

doi:10.1038/sj.bjc.6604188

Abstract | Full article | PDF
T Otsubo, Y Akiyama, K Yanagihara and Y Yuasa

SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis

advance online publication, 2008-02-12 00:00:00.000;

doi:10.1038/sj.bjc.6604193

Abstract | Full article | PDF
E A Griffiths, S A Pritchard, S M McGrath, H R Valentine, P M Price, I M Welch and C M L West

Hypoxia-associated markers in gastric carcinogenesis and HIF-2 in gastric and gastro-oesophageal cancer prognosis

advance online publication, 2008-02-19 00:00:00.000;

doi:10.1038/sj.bjc.6604210

Abstract | Full article | PDF
J Matsubara, T Nishina, Y Yamada, T Moriwaki, T Shimoda, T Kajiwara, T E Nakajima, K Kato, T Hamaguchi, Y Shimada, Y Okayama, T Oka and K Shirao

Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer

advance online publication, 2008-01-29 00:00:00.000;

doi:10.1038/sj.bjc.6604211

Abstract | Full article | PDF
F Gorouhi, F Islami, H Bahrami and F Kamangar

Tumour-necrosis factor-A polymorphisms and gastric cancer risk: a meta-analysis

advance online publication, 2008-03-04 00:00:00.000;

doi:10.1038/sj.bjc.6604277

Abstract | Full article | PDF
T Kubota

The role of S-1 in the treatment of gastric cancer

advance online publication, 2008-03-25 00:00:00.000;

doi:10.1038/sj.bjc.6604332

Abstract | Full article | PDF
G D Stewart, R J E Skipworth, C J Pennington, A G Lowrie, D A C Deans, D R Edwards, F K Habib, A C P Riddick, K C H Fearon and J A Ross

Variation in dermcidin expression in a range of primary human tumours and in hypoxic/oxidatively stressed human cell lines

doi:10.1038/sj.bjc.6604458

Abstract | Full article | PDF
J-L Lee, Y-K Kang, H J Kang, K-H Lee, D Y Zang, B-Y Ryoo, J G Kim, S R Park, W K Kang, D B Shin, M-H Ryu, H M Chang, T-W Kim, J H Baek and Y J Min

A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer

advance online publication, 2008-07-29 00:00:00.000;

doi:10.1038/sj.bjc.6604536

Abstract | Full article | PDF
A Takeno, I Takemasa, Y Doki, M Yamasaki, H Miyata, S Takiguchi, Y Fujiwara, K Matsubara and M Monden

Integrative approach for differentially overexpressed genes in gastric cancer by combining large-scale gene expression profiling and network analysis

advance online publication, 2008-09-30 00:00:00.000;

doi:10.1038/sj.bjc.6604682

Abstract | Full article | PDF
D Murray, G Horgan, P MacMathuna and P Doran

NET1-mediated RhoA activation facilitates lysophosphatidic acid-induced cell migration and invasion in gastric cancer

advance online publication, 2008-09-30 00:00:00.000;

doi:10.1038/sj.bjc.6604688

Abstract | Full article | PDF
Y Y Cheng, H Jin, X Liu, J M T Siu, Y P Wong, E K O Ng, J Yu, W-k Leung, J J Y Sung and F K L Chan

Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer

advance online publication, 2008-11-04 00:00:00.000;

doi:10.1038/sj.bjc.6604760

Abstract | Full article | PDF
T E Buffart, R M Overmeer, R D M Steenbergen, M Tijssen, N C T van Grieken, P J F Snijders, H I Grabsch, C J H van de Velde, B Carvalho and G A Meijer

MAL promoter hypermethylation as a novel prognostic marker in gastric cancer

advance online publication, 2008-11-11 00:00:00.000;

doi:10.1038/sj.bjc.6604777

Abstract | Full article | PDF
Y Kita, T Fukagawa, K Mimori, Y Kosaka, K Ishikawa, T Aikou, S Natsugoe, M Sasako and M Mori

Expression of uPAR mRNA in peripheral blood is a favourite marker for metastasis in gastric cancer cases

advance online publication, 2008-12-02 00:00:00.000;

doi:10.1038/sj.bjc.6604806

Abstract | Full article | PDF
S-W Han, D-Y Oh, S-A Im, S R Park, K-W Lee, H S Song, N-S Lee, K H Lee, I S Choi, M H Lee, M A Kim, W H Kim, Y-J Bang and T-Y Kim

Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer

advance online publication, 2009-01-06 00:00:00.000;

doi:10.1038/sj.bjc.6604861

Abstract | Full article | PDF
M Anders, M Vieth, C Röcken, M Ebert, M Pross, S Gretschel, P M Schlag, B Wiedenmann, W Kemmner and M Höcker

Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression

advance online publication, 2009-01-13 00:00:00.000;

doi:10.1038/sj.bjc.6604876

Abstract | Full article | PDF
C C Abnet, N D Freedman, F Kamangar, M F Leitzmann, A R Hollenbeck and A Schatzkin

Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis

advance online publication, 2009-01-20 00:00:00.000;

doi:10.1038/sj.bjc.6604880

Abstract | Full article | PDF
J D Barros-Silva, D Leitão, L Afonso, J Vieira, M Dinis-Ribeiro, M Fragoso, M J Bento, L Santos, P Ferreira, S Rêgo, C Brandão, F Carneiro, C Lopes, F Schmitt and M R Teixeira

Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients

advance online publication, 2009-01-20 00:00:00.000;

doi:10.1038/sj.bjc.6604885

Abstract | Full article | PDF
P Bertuccio, D Praud, L Chatenoud, E Lucenteforte, C Bosetti, C Pelucchi, M Rossi, E Negri and C La Vecchia

Dietary glycemic load and gastric cancer risk in Italy

doi:10.1038/sj.bjc.6604894

Abstract | Full article | PDF
T Murayama, M Inokuchi, Y Takagi, H Yamada, K Kojima, J Kumagai, T Kawano and K Sugihara

Relation between outcomes and localisation of p-mTOR expression in gastric cancer

advance online publication, 2009-02-17 00:00:00.000;

doi:10.1038/sj.bjc.6604915

Abstract | Full article | PDF
N Rohwer, S Lobitz, K Daskalow, T Jöns, M Vieth, P M Schlag, W Kemmner, B Wiedenmann, T Cramer and M Höcker

HIF-1 determines the metastatic potential of gastric cancer cells

advance online publication, 2009-02-17 00:00:00.000;

doi:10.1038/sj.bjc.6604919

Abstract | Full article | PDF
J-S Kim, M-A Kim, T M Kim, S-H Lee, D-W Kim, S-A Im, T-Y Kim, W H Kim, H-K Yang, D S Heo, Y-J Bang, K-U Lee, K-J Choe and N K Kim

Biomarker analysis in stage III–IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival

doi:10.1038/sj.bjc.6604936

Abstract | Full article | PDF
Y Hirata, N Ogasawara, M Sasaki, T Mizushima, T Shimura, T Mizoshita, Y Mori, E Kubota, T Wada, S Tanida, H Kataoka, T Kamiya, S Higashiyama and T Joh

BCL6 degradation caused by the interaction with the C-terminus of pro-HB-EGF induces cyclin D2 expression in gastric cancers

advance online publication, 2009-03-31 00:00:00.000;

doi:10.1038/sj.bjc.6605010

Abstract | Full article | PDF
M Iwatsuki, T Fukagawa, K Mimori, H Nakanishi, S Ito, H Ishii, T Yokobori, M Sasako, H Baba and M Mori

Bone marrow and peripheral blood expression of ID1 in human gastric carcinoma patients is a bona fide indicator of lymph node and peritoneal metastasis

advance online publication, 2009-06-02 00:00:00.000;

doi:10.1038/sj.bjc.6605085

Abstract | Full article | PDF
J A M Belien, T E Buffart, A J Gill, M A M Broeckaert, P Quirke, G A Meijer and H I Grabsch

Gross genomic damage measured by DNA image cytometry independently predicts gastric cancer patient survival

doi:10.1038/sj.bjc.6605266

Abstract | Full article | PDF
M Yaghoobi, R Bijarchi and S A Narod

Family history and the risk of gastric cancer

advance online publication, 2009-11-03 00:00:00.000;

doi:10.1038/sj.bjc.6605380

Abstract | Full article | PDF
G H Zhu and S K Lam

Non-steroidal anti-inflammatory drug-induced apoptosis in gastric cancer cells is blocked by protein kinase C activation through inhibition of c-myc

doi:10.1038/sj.bjc.6690062

Abstract | Full article | PDF
N Hayes, J Wayman, V Wadehra and S M Griffin

Peritoneal cytology in the surgical evaluation of gastric carcinoma

doi:10.1038/sj.bjc.6690081

Abstract | Full article | PDF
H Nekarda, C Ge, M Stark, U Fink, U Schenck and J R Siewert

Immunocytochemically detected free peritoneal tumour cells (FPTC) are a strong prognostic factor in gastric carcinoma

doi:10.1038/sj.bjc.6690096

Abstract | Full article | PDF
L P Setälä, M I Tammi, R H Tammi, M J Eskelinen, P K Lipponen, U M Agren, J Parkkinen, E M Alhava and V-M Kosma

Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate

doi:10.1038/sj.bjc.6690180

Abstract | Full article | PDF
Y Maehara, M Tomoda, S Hasuda, A Kabashima, E Tokunaga, Y Kakeji and K Sugimachi

Prognostic value of p53 protein expression for patients with gastric cancer - a multivariate analysis

doi:10.1038/sj.bjc.6690201

Abstract | Full article | PDF
A Cuschieri, S Weeden, J Fielding, J Bancewicz, J Craven, V Joypaul and M Sydes

Patient survival after D₁ and D₂ resections for gastric cancer: long-term results of the MRC randomized surgical trial

doi:10.1038/sj.bjc.6690243

Abstract | Full article | PDF
J Stone, S Bevan, D Cunningham, A Hill, N Rahman, J Peto, A Marossy and R S Houlston

Low frequency of germline E-cadherin mutations in familial and nonfamilial gastric cancer

doi:10.1038/sj.bjc.6690308

Abstract | Full article | PDF
S-Y Jiang, S-R Shen, R-Y Shyu, J-C Yu, H-J Harn, M-Y Yeh, M M-S Lee and Y-C Chang

Expression of nuclear retinoid receptors in normal, premalignant and malignant gastric tissues determined by in situ hybridization

doi:10.1038/sj.bjc.6690340

Abstract | Full article | PDF
Y Mori, M Matsunaga, T Abe, S Fukushige, K Miura, M Sunamura, K Shiiba, M Sato, T Nukiwa and A Horii

Chromosome band 16q24 is frequently deleted in human gastric cancer

doi:10.1038/sj.bjc.6690391

Abstract | Full article | PDF
M J S Langman, J A Dunn, J L Whiting, A Burton, M T Hallissey, J W L Fielding and D J Kerr

Prospective, double-blind, placebo-controlled randomized trial of cimetidine in gastric cancer

doi:10.1038/sj.bjc.6690457

Abstract | Full article | PDF
D Karat, I Brotherick, B K Shenton, D Scott, S A Raimes and S M Griffin

Expression of oestrogen and progesterone receptors in gastric cancer: a flow cytometric study

doi:10.1038/sj.bjc.6690497

Abstract | Full article | PDF
A Erog˘lu, S Demirci, A Ayyildiz, H Kocaog˘lu, H Akbulut, H Akgül and H A Elhan

Serum concentrations of vascular endothelial growth factor and nitrite as an estimate of in vivo nitric oxide in patients with gastric cancer

doi:10.1038/sj.bjc.6690573

Abstract | Full article | PDF
H Saito, S Tsujitani, S Oka, A Kondo, M Ikeguchi, M Maeta and N Kaibara

The expression of thymidine phosphorylase correlates with angiogenesis and the efficacy of chemotherapy using fluorouracil derivatives in advanced gastric carcinoma

doi:10.1038/sj.bjc.6690719

Abstract | Full article | PDF
C Kollmannsberger, D Quietzsch, C Haag, T Lingenfelser, M Schroeder, J T Hartmann, W Baronius, V Hempel, M Clemens, L Kanz and C Bokemeyer

A phase II study of paclitaxel, weekly, 24-hour continuous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer

doi:10.1054/bjoc.2000.1295

Abstract | Full article | PDF
N Mori, M Oka, S Hazama, N Iizuka, K Yamamoto, S Yoshino, A Tangoku, T Noma and K Hirose

Detection of telomerase activity in peritoneal lavage fluid from patients with gastric cancer using immunomagnetic beads

doi:10.1054/bjoc.2000.1408

Abstract | Full article | PDF
Y Maehara, Y Kakeji, S Oda, I Takahashi, K Akazawa and K Sugimachi

Time trends of surgical treatment and the prognosis for Japanese patients with gastric cancer

doi:10.1054/bjoc.2000.1427

Abstract | Full article | PDF
H Sato, S Ishihara, K Kawashima, N Moriyama, H Suetsugu, H Kazumori, T Okuyama, M A K Rumi, R Fukuda, N Nagasue and Y Kinoshita

Expression of peroxisome proliferator-activated receptor (PPAR) in gastric cancer and inhibitory effects of PPAR agonists

doi:10.1054/bjoc.2000.1457

Abstract | Full article | PDF
B Neri, G Cini, F Andreoli, B Boffi, D Francesconi, R Mazzanti, F Medi, A Mercatelli, S Romano, L Siliani, R Tarquini and R Moretti

Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up

doi:10.1054/bjoc.2000.1472

Abstract | Full article | PDF
E Klein Kranenbarg, J Hermans, J H J M van Krieken and C J H van de Velde

Evaluation of the 5th edition of the TNM classification for gastric cancer: improved prognostic value

doi:10.1054/bjoc.2000.1548

Abstract | Full article | PDF
J-H Choi, H-Y Lim, D K Nam, H S Kim, D Y Cho, J W Yi, H C Kim, Y K Cho, M W Kim, H J Joo, K B Lee and K B Kim

Expression of thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection

doi:10.1054/bjoc.2000.1553

Abstract | Full article | PDF
S Kaneko and T Yoshimura

Time trend analysis of gastric cancer incidence in Japan by histological types, 1975-1989

doi:10.1054/bjoc.2000.1602

Abstract | Full article | PDF
W K Leung, K-F To, Y-P Ng, T-L Lee, J Y W Lau, F K L Chan, E K W Ng, S C S Chung and J J Y Sung

Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer

doi:10.1054/bjoc.2000.1607

Abstract | Full article | PDF
S Cascinu, F Graziano, S Barni, R Labianca, G Comella, R Casaretti, L Frontini, V Catalano, A M Baldelli and G Catalano

A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer

doi:10.1054/bjoc.2000.1631

Abstract | Full article | PDF
C Sakakura, A Hagiwara, R Yasuoka, Y Fujita, M Nakanishi, K Masuda, K Shimomura, Y Nakamura, J Inazawa, T Abe and H Yamagishi

Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation

doi:10.1054/bjoc.2000.1684

Abstract | Full article | PDF
K Akre, A M Ekström, L B Signorello, L-E Hansson and O Nyrén

Aspirin and risk for gastric cancer: a population-based case-control study in Sweden

doi:10.1054/bjoc.2001.1702

Abstract | Full article | PDF
D H Roukos, M Lorenz, K Karakostas, P Paraschou, C Batsis and A M Kappas

Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: A prospective with quality control 10-yea

doi:10.1054/bjoc.2001.1720

Abstract | Full article | PDF
K Sato, G Tamura, T Tsuchiya, Y Endoh, O Usuba, W Kimura and T Motoyama

Frequent loss of expression without sequence mutations of theDCCgene in primary gastric cancer

doi:10.1054/bjoc.2001.1888

Abstract | Full article | PDF
G McFarlane, D Forman, F Sitas and G Lachlan

A minimum estimate for the incidence of gastric cancer in Eastern Kenya

doi:10.1054/bjoc.2001.1994

Abstract | Full article | PDF
S Ramesh, J Nash and P G McCulloch

Reduction in membranous expression of -catenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer

doi:10.1038/sj.bjc.6693437

Abstract | Full article | PDF
gastric cancer cells

S H Kang, Y-J Bang, H-S Jong, J Y Seo, N K Kim and S-J Kim

Rapid induction of p21^WAF1 but delayed down-regulation of Cdc25A in the TGF--induced cell cycle arrest of gastric carcinoma cells

doi:10.1038/sj.bjc.6690478

Abstract | Full article | PDF